Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Red Light Holland expands psilocybin research and supply after acquiring Filament Health.
TRIP
$14.61
+$0.61 +4.36%

Red Light Holland expands psilocybin research and supply after acquiring Filament Health.

Market News
07 May 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Red Light Holland has expanded its pharmaceutical-grade psilocybin manufacturing and research capabilities following its acquisition of Filament Health. The company has shipped Filament's botanical drug candidate, PEX010, to support multiple clinical studies in Canada and the U.S., including research on alcohol use disorder, post-concussion symptoms, and chronic pain. Additionally, shipments support compassionate use programs and quality control labs, reflecting growing demand for natural psilocybin in therapeutic settings. This acquisition positions Red Light as a global leader in psychedelic drug development and commercialization.

More News (TRIP)

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

In Q2 2026, Longleaf Small-Cap Fund saw positive contributions from New York real estate firms Alexander’s and Empire State Realty Trust, as well as travel company Tripadvisor. However, Boston Beer negatively impacted the quarter due to mixed short-t...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App